OHSU Knight Cancer Institute Research Groups:OCI Research Group Meetings: Difference between revisions

From OpenWetWare
Jump to navigationJump to search
Line 57: Line 57:


|--
|--
| 9/23/2011
| 9/21/2012
|Thomas Jacob
|  
|Fluorescent quantum dot nanoparticle technology for molecular assessment of oncogenic kinase signaling
|   
|Dr. Tania Vu’s lab in biomedical engineering
|  
|  
|--
|--
| <font color=red>10/7/2011</font>  
| <font color=red>9/28/2012</font>  
|Brett Sheppard
|
|Pancreatic Cancer- Setting the Stage
|Hematologic Malignancies -
|
|
|   
|   
|--
|--
|10/14/2011
|10/5/2012
|Eliot Spindel
|
|Targeting cholinergic signaling in lung cancer
|
|Dr. Eliot Spindel's lab:  Neuroscience meets lung cancer and lung development
|  
|  
|--
|--
| <font color=red>10/21/2011</font>  
| <font color=red>10/12/2012</font>  
|Soren Impey
|  
|Pancreas
|Hematologic Malignancies -
|  
|  
|   
|   
|--
|--
|10/28/2011
|10/19/2012
|
|
|
|
Line 87: Line 85:
|  
|  
|--
|--
| <font color=red>11/4/2011</font>  
| <font color=red>10/26/2012</font>  
|Philip Streeter
|
|Pancreas: Immunoassays for Detection of Early Pancreatic Cancer
|Hematologic Malignancies -
|  
|  
|  
|  
|--
|--
|<font color=red>11/11/2011</font>
|11/2/2012
|Joe Gray
|  
|Pancreas:  “Subtyping pancreatic cancers – advancing diagnosis and treatment”
|  
|  
|
|
|--
|--
| <font color=red>11/18/2011</font>  
| <font color=red>11/9/2012</font>  
|Fox Lab
|  
|Pancreas
|Hematologic Malignancies - 
|  
|  
|  
|  
|--
|--
| <font color=red>12/2/2011</font>
| 11/16/2012
|Rosie Sears
|
|Pancreas:
|  
|  
|  
|  
|--
|--
|12/9/2011
|<font color=red>11/30/2012</font>
|Charles Springer
|
|Can MRI Map the Angiogenic Switch in Human Breast Tumors in Vivo?
|Hematologic Malignancies -
|  
|  
|
|
|--
|--
| <font color=red>12/16/2011</font>
|12/7/2012
|
|
|Pancreas: Brain Storming
|  
|  
|  
|  
|--
|--
|1/6/2012  
|<font color=red>12/14/2012</font>
|CANCELLED
|
|
|Hematologic Malignancies - Brain storming
|  
|  
|  
|  
|--
|--
| <font color=red>1/13/2012</font>
|12/21/2012  
|
|
Steve Chui
Shiuh-Wen Luoh
| Breast Cancer: I-Spy-2 and tissue collection
|  
|  
|  
|  
|--
|--
| <font color=red>1/20/2012</font>  
| <font color=red>1/4/2013</font>  
|  
|
Megan Troxell
| Breast Cancer: Pathologist PI3K mutations in early breast cancer lesions
|  
|  
|
|
|--
|--
|1/27/2012
|1/11/2013
|Joshi Alumkal
|
|Thinking Outside the (Androgen) Box in Prostate Cancer
|
|  
|  
|
|
|--
|--
| <font color=red>2/3/2012</font>  
| <font color=red>1/18/2013</font>  
|  
|  
Rosie Sears
|
 
Jim Korkola
| Breast Cancer: Korkola: Combination Therapies and Irreversible Inhibitors for the treatment of HER2 positive breast cancer; Sears: Strategies to target c-Myc in breast cancer
|  
|  
|
|
|--
|--
|2/10/2012
|1/25/2013
|Steven Jacques
|
|Label-free optical imaging of cellular processes
|  
|  
|  
|  

Revision as of 10:20, 31 August 2012

Equipped with his five senses, man explores the universe around him and calls the adventure Science. ~Edwin Powell Hubble, The Nature of Science, 1954

Home        Faculty        Graduate Program        Postdocs        OHSU Knight Core Facilities       



Programs     Res Group Meetings        Cancer Journal Club        Cell/CANB 616        Gen. Inst/R3 Club     CANB 610    


Objectives of the OHSU Knight Cancer Biology Research Group Meetings

Cross-departmental workshop composed of students, postdocs, and faculty with shared interest in basic principles and emerging discoveries in Cancer Biology. The goals of the meetings and this wiki:

  • Establish a challenging and interactive cross-departmental focus group that will advance understanding of our individual projects and encourage collaborations.
  • Provide students and postdocs with training and interactions with faculty interested in Cancer Biology and emerging therapeutics

These meetings are now expanded to include a Translational Cancer Research Group Meeting. The purpose of this meeting is to:

  • Serve to foster a Knight translational research incubator for projects and teams leading to multi-investigator cancer program/SPORE funding including the Solid tumors and Hematologic Malignancies programs and the Systems Biology group.
  • Meetings will include thematic research and clinical research talks with collaborative and developmental potential and Brainstorming Sessions.

Knight Research Group Activities

Want to join us? All are invited!

To get on the listserve:
go to the following web site:
http://mailman.ohsu.edu/cgi-bin/mailman/listinfo/oncres
follow the instructions for subscribing
  • We meet in the Knight Conference Room 14th floor Hatfield Research Bldg
Fridays 9:15-10:15 AM - see schedule below
Breakfast provided by the Knight!
  • Organizer: Rosie Sears, email searsrATohsu.edu

Member Labs and Affiliations

Lopez Lab Hem Onc

Sears Lab, MMG

Hoatlin Lab, BMB

Thayer Lab, BMB

Lloyd Lab, CROET

McCullough Lab, CROET

Wong Lab, Dermatology, CDB

Zundel Lab, Radiation Medicine, Cancer Biology

Spindel Lab, Primate Center, NGP, Cancer Biology

  • Add your lab here

Schedule

*Red indicates Translational Cancer Research Group Meetings

Date Presenters Topic Links & Comments Location
9/21/2012
9/28/2012 Hematologic Malignancies -
10/5/2012
10/12/2012 Hematologic Malignancies -
10/19/2012
10/26/2012 Hematologic Malignancies -
11/2/2012
11/9/2012 Hematologic Malignancies -
11/16/2012
11/30/2012 Hematologic Malignancies -
12/7/2012
12/14/2012 Hematologic Malignancies - Brain storming
12/21/2012
1/4/2013
1/11/2013
1/18/2013
1/25/2013
2/17/2012

Lisa Coussens

Breast Cancer:Inflammation and Breast Cancer: Targeting Macrophages to Enhance Chemotherapy
2/24/2012 George Thomas Re-thinking Targeted Therapies for Kidney Cancer
3/2/2012 Juha Rantala

Koei Chin

Breast Cancer (Rantala): Targeted RNAi screens in breast cancer cells using cell spot microarrays.

Breast Cancer (Chin): Omics Analysis in Breast Cancer: Genome to Protein

3/9/2012 Daniel Marks Brain Mechanisms in Cancer Cachexia
3/16/2012 Xiangshu Xiao Breast Cancer: Small Molecules Targeting CREB for Breast Cancer Therapy
3/23/2012 Canceled for the 2012 BioMedicine in 4D Conference [1]
3/30/2012 NO MEETING Spring Break
4/6/2012 Allen Ebens, PhD The role of PI3 and PIM kinases in multiple myeloma ***Note the location change *** MAC HALL 2201
4/13/2012 Jen Vomaske CXCR7-mediated Endothelial Dysfunction: Implications for Tumor Vascular Normalization ***Note the location change *** MAC HALL 2201
4/20/2012 Zhi Hu

Wassana Yantasee

Part I. Optimization of therapeutic siRNA against HER2 (Hu)

Part II. Nanoparticle platform for siRNA delivery and HER2 silencing (Yantasee)

***Note the location change *** MAC HALL 2201
4/27/2012 Lucia Carbone Mechanisms of chromosomal rearrangement in evolution and cancer ***Note the location change *** MAC HALL 2201
5/4/2012 Joe Gray

Paul Spellman

Breast Cancer: Prospects for interrogating the signaling nanostructure of breast cancer

Breast Cancer:Genomic Analysis of Breast Cancers. Beyond TCGA

***Note the location change *** MAC HALL 2201
5/11/2012 Wong Lab (Nick Smith, Emily Bubbers) ***Note the location change *** MAC HALL 2201
5/18/2012 John Muschler

Sunjong Kwon

Breast Cancer

Sunjong Kwon: Quantitative Imaging of individual mRNAs and co-staining of protein in breast cancer cells

***Note the location change *** MAC HALL 2201
5/25/2012 Brainstorming - Breast Cancer Focus ***Note the location change *** MAC HALL 2201
6/8/2012 Kinrin Yamanaka (Dr. Stephen Lloyd lab) Molecular Targeting of Translesion Synthesis DNA Polymerases for Novel Combination Chemotherapy ***Note the location change *** MAC HALL 2201
6/15/2012 Liskay Lab Inhibiting occult clonal expansion of mutant cells as a mechanism of chemoprevention ***Note the location change *** MAC HALL 2201
6/22/2012 Neil Osheroff Vanderbilt ***Note the location change *** MAC HALL 2201
Retrieved from "https://openwetware.org/mediawiki/index.php?title=OHSU_Knight_Cancer_Institute_Research_Groups:OCI_Research_Group_Meetings&oldid=621811"